Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Author:
Meng SHA
1
;
Jun WANG
;
Jie CAO
;
Zhi-Hui ZOU
;
Xiao-ye QU
;
Zhi-feng XI
;
Chuan SHEN
;
Ying TONG
;
Jian-jun ZHANG
;
Seogsong JEONG
;
Qiang XIA
Author Information
- Publication Type:Review
- From:Clinical and Molecular Hepatology 2025;31(Suppl):S285-S300
- CountryRepublic of Korea
- Language:English
- Abstract: Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated death globally. Liver transplantation (LT) has emerged as a key treatment for patients with HCC, and the Milan criteria have been adopted as the cornerstone of the selection policy. To allow more patients to benefit from LT, a number of expanded criteria have been proposed, many of which use radiologic morphological characteristics with larger and more tumors as surrogates to predict outcomes. Other groups developed indices incorporating biological variables and dynamic markers of response to locoregional treatment. These expanded selection criteria achieved satisfactory results with limited liver supplies. In addition, a number of prognostic models have been developed using clinicopathological characteristics, imaging radiomics features, genetic data, and advanced techniques such as artificial intelligence. These models could improve prognostic estimation, establish surveillance strategies, and bolster long-term outcomes in patients with HCC. In this study, we reviewed the latest findings and achievements regarding the selection criteria and post-transplant prognostic models for LT in patients with HCC.
